Gilead Sciences (GILD) Long-Term Deferred Tax (2009 - 2026)

Gilead Sciences (GILD) has reported Long-Term Deferred Tax for 12 consecutive years, with $1.8 billion the latest figure, recorded in Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $1.8 billion, down 31.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 31.3% YoY), and the FY2025 annual result was $2.0 billion, down 17.41% from the prior year.
• Long-Term Deferred Tax was $1.8 billion for Q1 2026 at Gilead Sciences, down from $2.0 billion in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $2.7 billion in Q2 2025 and troughed at $1.8 billion in Q1 2026.
• Average Long-Term Deferred Tax over 3 years is $2.2 billion, with a median of $2.2 billion recorded in 2024.
• Year-over-year, Long-Term Deferred Tax decreased 17.41% in 2025 and slumped 31.3% in 2026.
• Over 3 years, Long-Term Deferred Tax stood at $2.4 billion in 2024, then declined by 17.41% to $2.0 billion in 2025, then slipped by 10.03% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $1.8 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.0 billion in Q3 2025.